Mesh Bio: The role of deep tech in modern healthcare
What if we can prevent catastrophic diseases such as diabetes, kidney failure, and stroke with deep tech? The word deep tech might still be unfamiliar to people’s ears as it first emerged in 2014.
Mesh Bio raises US$3.5 million of Series A funding led by East Ventures, to make its digital twin technologies available at scale
Mesh Bio, a Singapore-based health deep tech startup transforming chronic disease management through predictive analytics, announced today that it has raised US$3.5 million in Series A financing led by East Ventures, a pioneering and leading sector-agnostic venture capital firm focusing on Southeast Asia. This round of investment is also participated by Elev8, Seed Capitals, and other existing shareholders.
Aevice Health secures investment from East Ventures to bring next-generation remote respiratory platform to Southeast Asia
Aevice Health, a leading provider of remote respiratory monitoring solutions for the healthcare continuum based in Singapore, today announced that it has raised undisclosed funding from East Ventures, a pioneering and leading sector-agnostic venture capital firm focusing on Southeast Asia.